# Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants

> **NCT03014115** · NA · COMPLETED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 110 (actual)

## Conditions studied

- Healthy Infants

## Interventions

- **DIETARY_SUPPLEMENT:** combination ARA + DHA
- **DIETARY_SUPPLEMENT:** DHA

## Key facts

- **NCT ID:** NCT03014115
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-05
- **Final completion:** 2019-08
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03014115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03014115, "Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03014115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*